Relapsed Disease
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia (NCT05576532) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2023-01-10 |
Track Relapsed Disease automatically
Every clearance here is in the API, with alerts when new ones post.